Research Reports

Find premium research reports, analysis, and business reports. Purchase and download high-quality research reports utility documents for any type of industry and business.

DocStore Search:
Per Page: 152550
  • Primary Health Care Ltd (PRY) - Financial and Strategic SWOT Analysis Review
    Primary Health Care Ltd (PRY) - Financial and Strategic SWOT Analysis Review

    $125.00

    $125.00

    From:GlobalData

    Document Overview:
    Primary Health Care Ltd (PRY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better. The profile contains critical company information including: - Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – Analyst’s summarization of the company’s business strategy. - SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the company. - Major products and services – A list of major products, services and brands of the company. - Key competitors – A list of key competitors to the company. - Key employees – A list of the key executives of the company. - Executive biographies – A brief summary of the executives’ employment history. - Key operational heads – A list of personnel heading key departments/functions. - Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company. - Key manufacturing facilities – A list of key manufacturing facilities of the company. - Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history. - Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history. Highlights Primary Health Care Limited (PHC) is a healthcare service provider. The company offers a wide
    View Document
  • Hanmi Science Co., Ltd. (008930) - Financial and Strategic SWOT Analysis Review
    Hanmi Science Co., Ltd. (008930) - Financial and Strategic SWOT Analysis Review

    $125.00

    $125.00

    From:GlobalData

    Document Overview:
    Hanmi Science Co., Ltd. (008930) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better. The profile contains critical company information including: - Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – Analyst’s summarization of the company’s business strategy. - SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the company. - Major products and services – A list of major products, services and brands of the company. - Key competitors – A list of key competitors to the company. - Key employees – A list of the key executives of the company. - Executive biographies – A brief summary of the executives’ employment history. - Key operational heads – A list of personnel heading key departments/functions. - Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company. - Key manufacturing facilities – A list of key manufacturing facilities of the company. - Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history. - Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history. Highlights Hanmi Science Co., Ltd. (Hanmi Science) is a pharmaceutical company. The company operates
    View Document
  • Jeil Pharmaceutical Co., Ltd. (002620) - Financial and Strategic SWOT Analysis Review
    Jeil Pharmaceutical Co., Ltd. (002620) - Financial and Strategic SWOT Analysis Review

    $125.00

    $125.00

    From:GlobalData

    Document Overview:
    Jeil Pharmaceutical Co., Ltd. (002620) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better. The profile contains critical company information including: - Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – Analyst’s summarization of the company’s business strategy. - SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the company. - Major products and services – A list of major products, services and brands of the company. - Key competitors – A list of key competitors to the company. - Key employees – A list of the key executives of the company. - Executive biographies – A brief summary of the executives’ employment history. - Key operational heads – A list of personnel heading key departments/functions. - Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company. - Key manufacturing facilities – A list of key manufacturing facilities of the company. - Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history. - Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history. Highlights Jeil Pharmaceutical Co., Ltd. (Jeil) is a pharmaceutical company. The company offers
    View Document
  • Dr. Reddy's Laboratories Limited (DRREDDY) - Financial and Strategic SWOT Analysis Review
    Dr. Reddy's Laboratories Limited (DRREDDY) - Financial and Strategic SWOT Analysis Review

    $125.00

    $125.00

    From:GlobalData

    Document Overview:
    Dr. Reddy's Laboratories Limited (DRREDDY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better. The profile contains critical company information including: - Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – Analyst’s summarization of the company’s business strategy. - SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the company. - Major products and services – A list of major products, services and brands of the company. - Key competitors – A list of key competitors to the company. - Key employees – A list of the key executives of the company. - Executive biographies – A brief summary of the executives’ employment history. - Key operational heads – A list of personnel heading key departments/functions. - Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company. - Key manufacturing facilities – A list of key manufacturing facilities of the company. - Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history. - Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history. Highlights Dr. Reddy's Laboratories Limited (Dr. Reddy's) is a pharmaceutical ingredient co
    View Document
  • Cipla Ltd. (CIPLA) - Financial and Strategic SWOT Analysis Review
    Cipla Ltd. (CIPLA) - Financial and Strategic SWOT Analysis Review

    $125.00

    $125.00

    From:GlobalData

    Document Overview:
    Cipla Ltd. (CIPLA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better. The profile contains critical company information including: - Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – Analyst’s summarization of the company’s business strategy. - SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the company. - Major products and services – A list of major products, services and brands of the company. - Key competitors – A list of key competitors to the company. - Key employees – A list of the key executives of the company. - Executive biographies – A brief summary of the executives’ employment history. - Key operational heads – A list of personnel heading key departments/functions. - Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company. - Key manufacturing facilities – A list of key manufacturing facilities of the company. - Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history. - Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history. Highlights Cipla Ltd. (Cipla) is a pharmaceutical company. The company develops and markets generic pharmaceutical
    View Document
  • Ego Pharmaceuticals Pty Ltd - Strategic SWOT Analysis Review
    Ego Pharmaceuticals Pty Ltd - Strategic SWOT Analysis Review

    $125.00

    $125.00

    From:GlobalData

    Document Overview:
    Ego Pharmaceuticals Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better. Scope - Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – GlobalData’s summarization of the company’s business strategy. - SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the company. - Major products and services – A list of major products, services and brands of the company. - Key competitors – A list of key competitors to the company. - Key employees – A list of the key executives of the company. - Executive biographies – A brief summary of the executives’ employment history. - Key operational heads – A list of personnel heading key departments/functions. - Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details. - Key manufacturing facilities – A list of key manufacturing facilities of the company. Highlights Ego Pharmaceuticals Pty Ltd (EPP) is a pharmaceutical company. The company develops and markets skin and health care products. Its products include Azclear medicated lotion, Hairscience purifying shampoo and Volumising conditioner, Azclear action foaming wash, SunSense Ultra, SunSense sport, SunSense kids, SunSense clear mist, QV face moisturising day cream, QV cream, and QV skin lotion. Reasons to Buy - Gain key insights into the company for academic or business research purposes. Key elements s
    View Document
  • Harbin Pharmaceutical Group Co., Ltd. (600664) - Financial and Strategic SWOT Analysis Review
    Harbin Pharmaceutical Group Co., Ltd. (600664) - Financial and Strategic SWOT Analysis Review

    $125.00

    $125.00

    From:GlobalData

    Document Overview:
    Harbin Pharmaceutical Group Co., Ltd. (600664) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better. The profile contains critical company information including: - Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – Analyst’s summarization of the company’s business strategy. - SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the company. - Major products and services – A list of major products, services and brands of the company. - Key competitors – A list of key competitors to the company. - Key employees – A list of the key executives of the company. - Executive biographies – A brief summary of the executives’ employment history. - Key operational heads – A list of personnel heading key departments/functions. - Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company. - Key manufacturing facilities – A list of key manufacturing facilities of the company. - Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history. - Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history. Highlights Harbin Pharmaceutical Group Co., Ltd. (HPGC) is a state controlled Sino-fore
    View Document
  • Pharco Corporation - Strategic SWOT Analysis Review
    Pharco Corporation - Strategic SWOT Analysis Review

    $125.00

    $125.00

    From:GlobalData

    Document Overview:
    Pharco Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better. Scope - Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – GlobalData’s summarization of the company’s business strategy. - SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the company. - Major products and services – A list of major products, services and brands of the company. - Key competitors – A list of key competitors to the company. - Key employees – A list of the key executives of the company. - Executive biographies – A brief summary of the executives’ employment history. - Key operational heads – A list of personnel heading key departments/functions. - Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details. - Key manufacturing facilities – A list of key manufacturing facilities of the company. Highlights Pharco Corporation (Pharco) is a pharmaceutical products manufacturer. The company develops, manufactures, distributes and exports branded and generic drugs. It offers products in dosage forms including tablets, hard gelatin capsules, soft gelatin capsules, sachets, syrups, sprays, suppositories, drops, ampoules, powder for oral suspension (POS) and sterile vials. The company provides antiflatulent, digestant, antacid, antispasmodic, gastrokinetic, antipyretic, choleretic and laxative products. Pharco provides
    View Document
  • Rekah Pharmaceutical Industry Ltd. (REKA) - Financial and Strategic SWOT Analysis Review
    Rekah Pharmaceutical Industry Ltd. (REKA) - Financial and Strategic SWOT Analysis Review

    $125.00

    $125.00

    From:GlobalData

    Document Overview:
    Rekah Pharmaceutical Industry Ltd. (REKA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better. The profile contains critical company information including: - Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – Analyst’s summarization of the company’s business strategy. - SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the company. - Major products and services – A list of major products, services and brands of the company. - Key competitors – A list of key competitors to the company. - Key employees – A list of the key executives of the company. - Executive biographies – A brief summary of the executives’ employment history. - Key operational heads – A list of personnel heading key departments/functions. - Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company. - Key manufacturing facilities – A list of key manufacturing facilities of the company. - Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history. - Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history. Highlights Rekah Pharmaceutical Industry Ltd. (Rekah) is a pharmaceutical company. The compa
    View Document
  • Luye Pharma Group Ltd. - Strategic SWOT Analysis Review
    Luye Pharma Group Ltd. - Strategic SWOT Analysis Review

    $125.00

    $125.00

    From:GlobalData

    Document Overview:
    Luye Pharma Group Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better. Scope - Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – GlobalData’s summarization of the company’s business strategy. - SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the company. - Major products and services – A list of major products, services and brands of the company. - Key competitors – A list of key competitors to the company. - Key employees – A list of the key executives of the company. - Executive biographies – A brief summary of the executives’ employment history. - Key operational heads – A list of personnel heading key departments/functions. - Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details. - Key manufacturing facilities – A list of key manufacturing facilities of the company. Highlights Luye Pharma Group Ltd. (Luye Pharma) is a biopharmaceutical drug manufacturer. The company discovers, develops, manufactures and commercializes natural drugs, novel formulations and biotechnology products. Its products include sodium glycididazole, paclitaxel liposome, lentinan, amifostine, oxaliplatin, arsenious acid, xuezhikang, pioglitazone hydrochloride, meloxicam, reduced glutathione and selegiline hydrochloride. Luye Pharma offers products under various brands such as CMNa, Lipusu, Tiandixin, Tiandida
    View Document
  • Fidson Healthcare Plc (FIDSON) - Financial and Strategic SWOT Analysis Review
    Fidson Healthcare Plc (FIDSON) - Financial and Strategic SWOT Analysis Review

    $125.00

    $125.00

    From:GlobalData

    Document Overview:
    Fidson Healthcare Plc (FIDSON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better. The profile contains critical company information including: - Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – Analyst’s summarization of the company’s business strategy. - SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the company. - Major products and services – A list of major products, services and brands of the company. - Key competitors – A list of key competitors to the company. - Key employees – A list of the key executives of the company. - Executive biographies – A brief summary of the executives’ employment history. - Key operational heads – A list of personnel heading key departments/functions. - Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company. - Key manufacturing facilities – A list of key manufacturing facilities of the company. - Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history. - Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history. Highlights Fidson Healthcare Plc (Fidson) is a pharmaceutical company. The company manufactures and dis
    View Document
  • G.L. Pharma GmbH - Strategic SWOT Analysis Review
    G.L. Pharma GmbH - Strategic SWOT Analysis Review

    $125.00

    $125.00

    From:GlobalData

    Document Overview:
    G.L. Pharma GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better. Scope - Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – GlobalData’s summarization of the company’s business strategy. - SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the company. - Major products and services – A list of major products, services and brands of the company. - Key competitors – A list of key competitors to the company. - Key employees – A list of the key executives of the company. - Executive biographies – A brief summary of the executives’ employment history. - Key operational heads – A list of personnel heading key departments/functions. - Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details. - Key manufacturing facilities – A list of key manufacturing facilities of the company. Highlights G.L. Pharma GmbH (G.L. Pharma) is a pharmaceutical company. The company develops and markets drugs. Its products include Acelisino comp. forte, Acelisino comp. mite, Aclop, Adjuvin, Adjuvin, Aedon, Aglandin, Aleptan, Alcover, Allernon, Amlodilan, Amoxilan, Anaerobex, Androbloc, Anastrolan, Androfin film, Antiflat, Anxiolit forte, Ascalan, Ascorbisal, Atenolan, Bupensan, Calmolan, Candeblo plus, Capecel, and Ciflox. G.L. Pharma provides products in film-coated tablets, capsules, chewable tablets, ampoules, solutio
    View Document
  • KAEL-GemVax Co., Ltd. - Strategic SWOT Analysis Review
    KAEL-GemVax Co., Ltd. - Strategic SWOT Analysis Review

    $125.00

    $125.00

    From:GlobalData

    Document Overview:
    KAEL-GemVax Co., Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better. Scope - Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – GlobalData’s summarization of the company’s business strategy. - SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the company. - Major products and services – A list of major products, services and brands of the company. - Key competitors – A list of key competitors to the company. - Key employees – A list of the key executives of the company. - Executive biographies – A brief summary of the executives’ employment history. - Key operational heads – A list of personnel heading key departments/functions. - Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details. - Key manufacturing facilities – A list of key manufacturing facilities of the company. Highlights KAEL-GemVax Co.,Ltd. (KAEL-GemVax) is a pharmaceutical products manufacturer. The company develops and commercializes vaccines for the treatment of cancer using its technology platform. Its products include cancer vaccine, anti-inflammation and GV1001. KAEL-GemVax conducts clinical trials in the fields of melanoma, liver cancer, lung cancer and pancreatic cancer. The company also conducts pre-clinical study in cachexia, renal disease and benign prostatic hyperplasia. It partners with Orion Clinical Services,
    View Document
  • New Zealand Pharmaceuticals Limited - Strategic SWOT Analysis Review
    New Zealand Pharmaceuticals Limited - Strategic SWOT Analysis Review

    $125.00

    $125.00

    From:GlobalData

    Document Overview:
    New Zealand Pharmaceuticals Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better. Scope - Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – GlobalData’s summarization of the company’s business strategy. - SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the company. - Major products and services – A list of major products, services and brands of the company. - Key competitors – A list of key competitors to the company. - Key employees – A list of the key executives of the company. - Executive biographies – A brief summary of the executives’ employment history. - Key operational heads – A list of personnel heading key departments/functions. - Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details. - Key manufacturing facilities – A list of key manufacturing facilities of the company. Highlights New Zealand Pharmaceuticals Ltd. (NZ Pharma) is a biotechnology service provider. The company extracts and purifies biochemicals from by-products of the New Zealand meat processing industry. Its products include cholic acid, dehydrocholic acid, methyl cholate, peracetylated mannosamine, sodium cholate, natural taurine, deoxycholic acid, glycocholic acid, bile salts, sodium cholate, sodium deoxycholate, peracetylated mannosamine, sialic acid and mixed bile acids. New Zealand Pharmaceuticals L
    View Document
  • China Nuokang Bio-Pharmaceutical Inc. - Strategic SWOT Analysis Review
    China Nuokang Bio-Pharmaceutical Inc. - Strategic SWOT Analysis Review

    $125.00

    $125.00

    From:GlobalData

    Document Overview:
    China Nuokang Bio-Pharmaceutical Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better. Scope - Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – GlobalData’s summarization of the company’s business strategy. - SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the company. - Major products and services – A list of major products, services and brands of the company. - Key competitors – A list of key competitors to the company. - Key employees – A list of the key executives of the company. - Executive biographies – A brief summary of the executives’ employment history. - Key operational heads – A list of personnel heading key departments/functions. - Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details. - Key manufacturing facilities – A list of key manufacturing facilities of the company. Highlights China Nuokang Bio-Pharmaceutical Inc. (China Nuokang) is a biopharmaceutical company. The company develops, manufactures and markets hematological and cardiovascular products. Its products include Baquting and Aiduo. China Nuokang’s Baquting is a hemocoagulase product that holds proteolytic enzyme batroxobin, which promotes the blood coagulation process. The company’s Aiduo is an injectible coronary vasodilator, which is used as a diagnostic agent in connection with myocardial perfusion imagi
    View Document
Per Page: 152550